Global IV Iron Drugs Market Report: 2014 Edition – New Report by Koncept Analytics

DELHI, India - June 11, 2014 - PRLog -- Females with heavy menstrual periods may be iron deficient, which would require intravenous treatments. Further, women in their childbearing years have greater iron needs than men because menstrual blood loss causes iron deficiency that might create problems during pregnancy and childbirth.

As per the report “Global IV Iron Market: 2014 Edition” by Koncept Analytics, the demand for IV iron products will be driven by changing demographics, increasing healthcare expenditures, and rising number of patients suffering from diabetes and hypertension. Iron is among the vital minerals present in the human body and decline in the supply of iron can lead to severe health problems. The balance of iron in the body primarily is a combined result of three dynamics- intake, losses and metabolic demand.

Iron is a component of hemoglobin, the substance present in RBCs that transports oxygen throughout the body via blood. This oxygen is used by the cells for generating energy required to perform the necessary body functions. Usually oral iron supplements are recommended for restoring and maintaining iron levels in the body, but oral treatment has certain limitations. For the cases where oral supplements are incapable of fulfilling the purpose, IV iron therapy is used as part of which iron is directly injected with a needle into a vein. Some of the major areas of IV iron application include gynecology, gastroenterology, oncology and surgeries.Hemoglobin, Ferritin, Transferrin, and Hepcidin are major molecules which are critical in the function and regulation of iron.

Note:  Purchase by Section Also Available

The report by Koncept Analytics presents an exhaustive study of global iron products industry along with an in-depth analysis of global and the US IV iron market. It also encompasses a number of factors driving the growth of the global IV iron industry coupled with recent trends and challenges hindering the growth of the industry. The company profile section of the report covers detailed description of the three major players; Galenica Pharmaceuticals, Actavis Inc, AMAG Pharmaceuticals; operating in the global IV iron market. By deploying SPSS Inc.’s data integration and analysis capabilities, future growth prediction in terms of value of the global IV iron market has also been analyzed in the report.

List of Charts

Global Iron Products Market (2009-2013)
Global Iron Products Market Share – by Segments (2013)
Global Iron Products Value – by Segments (2013)
Global IV Iron Market (2009-2013)
The US IV Iron Market Size (2009-2013)
US Non-Dialysis IV Iron Market (2011-2013)
IV Iron – Avoidance of ESA Initiation in Pre Dialysis Patients
Global Health Care Expenditure Per Capita (2007-2012)
The US Healthcare Expenditure per Capita (2007-2012)
Global Urban Population (2007-2012)
The US Urban Population (2007-2012)
Global Aging Population (Over 65) as a Percentage of Total Population (2008-2012)
The US Aging Population (2008-2012)
Global Dialysis Patient Population
Dialysis Patient Population Share by Region (2012)
Worldwide Patients with End Stage Renal Disease (2005-2013)
Hypertension Prevalence in the US (2010-2015E)
Hypertension Prevalence in the Developed Europe (2010-2015E)
Global GDP (2007-2012)
World Gross National Income (2008-2012)
Global Life Expectancy Rate (2007-2012)
The US Life Expectancy Rate (2007-2013E)
Global Insurance Density (2004-2013)
Global Spending on Medicines (2006-2016E)
Global Spending on Medicine Share by Region (2006-2016E)
The US Spending on Medicine (2007-2016E)
Japan’s Spending on Medicine (2007-2016E)
Long and Short Term Concerns about IV Iron
IV Iron Market Share in the US (2013E)
Non-Dialysis IV Iron Market in the US – by Volume (Q114)
Galenica’s Revenue Share by Business Segments (2012)
Galenica’s Net Sales and Net Profit (2009-2013)
Actavis’ Revenue Share by Business Segment (2013)
Actavis’ Revenues and Net Income (2009-2013)
AMAG Pharmaceuticals’ Revenues (2009-2013)
Global IV Iron Market Forecast (2009-2018F)

Note:  Purchase by Section Also Available

List of Tables

Risk Factors for CKD
FDA Approved IV Iron Products
SFP Clinical Trials
IV Iron Products – Safety Profile
IV Iron Administration Comparison
Dependent & Independent Variables (2007-2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

For more Information:

http://www.konceptanalytics.com/Researchreport/global-iv-iron-drugs-market-report-2014-edition-133.aspx

Koncept Analytics

Vikas Gupta

(Business Development Manager)

FFCS-36, Ansal Plaza

Vaishali, Ghaziabad

U.P - 201010

Tele: +91-120-4130959

Mobile: +91-9811715635

Mail ID – vikas@konceptanalytics.com